GlaxoSmithKline Pharmaceuticals Ltd. - Research Center
500660 GLAXO Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Sales | 811.00 | 910.87 | 804.98 | 953.38 | 738.02 |
| Operating profit | 229.42 | 255.31 | 217.51 | 286.58 | 141.25 |
| Interest | 0.37 | 0.77 | 0.32 | 0.43 | 0.28 |
| Gross profit | 264.90 | 284.41 | 245.53 | 314.62 | 177.77 |
| EPS (Rs) | 10.72 | 11.40 | 2.69 | 12.72 | 7.71 |
Quarterly
results in details
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Other income | 35.85 | 29.87 | 28.34 | 28.47 | 36.80 |
| Stock adjustment | -13.26 | -98.90 | 63.93 | 9.71 | -44.38 |
| Raw material | 133.33 | 192.29 | 87.52 | 79.71 | 145.47 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 151.28 | 172.83 | 141.35 | 145.21 | 165.00 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 310.23 | 389.34 | 294.67 | 432.17 | 330.68 |
| Provisions made | - | - | - | - | - |
| Depreciation | 16.41 | 18.10 | 17.11 | 18.11 | 16.36 |
| Taxation | 66.84 | 75.63 | 19.62 | 80.97 | 48.13 |
| Net profit / loss | 181.65 | 193.08 | 45.49 | 215.54 | 130.58 |
| Extra ordinary item | - | 2.40 | -163.31 | - | 17.30 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 28.29 | 28.03 | 27.02 | 30.06 | 19.14 |
| GPM (%) | 31.28 | 30.23 | 29.46 | 32.04 | 22.94 |
| NPM (%) | 21.45 | 20.52 | 5.46 | 21.95 | 16.85 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis